Angiodynamics Inc (ANGO)

R&D Expense Growth

-2.43%

Quarterly · Period ending:

ANGO logo

ANGO R&D Expense Growth

Latest reported-2.43%
ANGO Quarterly R&D Growth (QoQ) (0.00% → -2.43%)
High-resolution chart · PNG

ANGO r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Angiodynamics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-2.4334%
15.4433%
-8.8054%
21.0535%
-2.6252%
-4.6724%
7.4448%
2.3707%
-6.5289%
-17.8899%
-5.417%
9.0291%
1.0305%
14.711%
0.2047%
-17.9407%
5.9369%
8.0495%
-11.2087%
10.8872%
-18.783%
6.2931%
-11.8101%
7.8033%
24.5713%
-13.8535%
8.1273%
23.3948%
-12.6111%
-0.1387%
-2.078%
-3.9024%
18.7171%
-0.0465%
5.7311%
-5.1855%
-3.8082%
12.5189%
0.6427%
-11.8647%
-3.2867%
19.4387%
-6.0042%
-0.3708%
-14.9129%
6.3311%
12.9511%
-9.6606%
-0.5183%
-4.1448%
0.5997%
4.3822%
4.2094%
11.1341%
-17.408%
-0.8482%
35.4653%
14.167%
-10.7512%
-8.3348%
0.7569%
4.2653%
1.1979%
0.3243%
-2.4563%
25.2973%
-9.9517%
-1.7736%
0.2896%
3.0477%
6.0339%
11.686%
-2.5098%
2.756%
7.0655%
36.2597%
-10.9103%
-78.6426%
770.3726%
0.6146%
19.7204%
-6.0166%
-6.4078%
1.7117%
17.3879%
26.1209%
-8.5561%
-0.5319%
18.239%
10.1617%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.